Raymond James & Associates’s Synopsys SNPS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $80M | Sell |
157,948
-64,110
| -29% | -$34.4M | 0.05% | 323 |
|
|
2024
Q2 | $132M | Buy |
222,058
+48,552
| +28% | +$27.5M | 0.09% | 198 |
|
|
2024
Q1 | $99.2M | Buy |
173,506
+48,543
| +39% | +$26.7M | 0.07% | 259 |
|
|
2023
Q4 | $64.3M | Buy |
124,963
+6,532
| +6% | +$3.34M | 0.05% | 322 |
|
|
2023
Q3 | $54.4M | Buy |
118,431
+28,739
| +32% | +$12.9M | 0.05% | 331 |
|
|
2023
Q2 | $39.1M | Buy |
89,692
+1,829
| +2% | +$737K | 0.03% | 435 |
|
|
2023
Q1 | $33.9M | Buy |
87,863
+558
| +0.6% | +$199K | 0.03% | 474 |
|
|
2022
Q4 | $27.9M | Sell |
87,305
-13,514
| -13% | -$4.23M | 0.03% | 527 |
|
|
2022
Q3 | $30.8M | Sell |
100,819
-1,325
| -1% | -$449K | 0.03% | 444 |
|
|
2022
Q2 | $31M | Buy |
102,144
+14,664
| +17% | +$4.42M | 0.03% | 452 |
|
|
2022
Q1 | $29.2M | Sell |
87,480
-53,740
| -38% | -$16.8M | 0.02% | 538 |
|
|
2021
Q4 | $52M | Buy |
141,220
+10,895
| +8% | +$3.67M | 0.04% | 370 |
|
|
2021
Q3 | $39M | Buy |
130,325
+6,033
| +5% | +$1.83M | 0.04% | 433 |
|
|
2021
Q2 | $34.3M | Sell |
124,292
-3,558
| -3% | -$903K | 0.03% | 469 |
|
|
2021
Q1 | $31.7M | Sell |
127,850
-24,770
| -16% | -$6.29M | 0.03% | 463 |
|
|
2020
Q4 | $39.6M | Buy |
152,620
+975
| +0.6% | +$225K | 0.04% | 364 |
|
|
2020
Q3 | $32.4M | Sell |
151,645
-18,640
| -11% | -$3.79M | 0.04% | 368 |
|
|
2020
Q2 | $33.2M | Sell |
170,285
-3,299
| -2% | -$544K | 0.04% | 344 |
|
|
2020
Q1 | $22.4M | Buy |
173,584
+50,074
| +41% | +$7.12M | 0.04% | 421 |
|
|
2019
Q4 | $17.2M | Sell |
123,510
-11,474
| -9% | -$1.57M | 0.02% | 651 |
|
|
2019
Q3 | $18.5M | Sell |
134,984
-7,013
| -5% | -$948K | 0.03% | 577 |
|
|
2019
Q2 | $18.3M | Buy |
141,997
+15,065
| +12% | +$1.81M | 0.03% | 573 |
|
|
2019
Q1 | $14.6M | Buy |
126,932
+6,625
| +6% | +$657K | 0.02% | 639 |
|
|
2018
Q4 | $10.1M | Sell |
120,307
-6,764
| -5% | -$601K | 0.02% | 750 |
|
|
2018
Q3 | $12.5M | Buy |
127,071
+41,062
| +48% | +$3.91M | 0.02% | 721 |
|
|
2018
Q2 | $7.36M | Buy |
86,009
+3,074
| +4% | +$268K | 0.01% | 970 |
|
|
2018
Q1 | $6.9M | Buy |
82,935
+8,890
| +12% | +$781K | 0.01% | 967 |
|
|
2017
Q4 | $6.31M | Sell |
74,045
-3,630
| -5% | -$314K | 0.01% | 1007 |
|
|
2017
Q3 | $6.25M | Sell |
77,675
-575
| -0.7% | -$44.6K | 0.01% | 973 |
|
|
2017
Q2 | $5.71M | Buy |
78,250
+37,509
| +92% | +$2.76M | 0.01% | 979 |
|
|
2017
Q1 | $2.94M | Buy |
40,741
+29,637
| +267% | +$1.98M | 0.01% | 1304 |
|
|
2016
Q4 | $654K | Sell |
11,104
-45
| -0.4% | -$2.68K | ﹤0.01% | 2166 |
|
|
2016
Q3 | $662K | Buy |
11,149
+1,002
| +10% | +$56.9K | ﹤0.01% | 2106 |
|
|
2016
Q2 | $549K | Sell |
10,147
-456
| -4% | -$22.9K | ﹤0.01% | 2063 |
|
|
2016
Q1 | $514K | Buy |
+10,603
| New | +$468K | ﹤0.01% | 2024 |
|
|
2015
Q4 | – | Sell |
-13,837
| Closed | -$639K | – | 2393 |
|
|
2015
Q3 | $639K | Buy |
13,837
+1,083
| +8% | +$53.2K | ﹤0.01% | 1821 |
|
|
2015
Q2 | $646K | Buy |
+12,754
| New | +$621K | ﹤0.01% | 1959 |
|
Other funds holding SNPS
Raymond James & Associates's SNPS Position: Q3 2024 in Review
Raymond James & Associates reduced its Synopsys (SNPS) stake by 29% in Q3 2024, selling an estimated $34.4M and leaving 157,948 shares worth $80M. The position accounts for 0.05% of the portfolio, ranked #323.
Raymond James & Associates first reported a position in SNPS in Q2 2015 and has held it in 37 quarters since. The position peaked at $132M in Q2 2024. 1,243 funds tracked by Wall St. Rank hold SNPS as of Q3 2024.
- Raymond James & Associates held 157,948 shares of Synopsys worth $80M as of Q3 2024.
- Raymond James & Associates sold 64,110 Synopsys shares in Q3 2024, an estimated $34.4M.
- Synopsys made up 0.05% of Raymond James & Associates's portfolio in Q3 2024, its #323 holding.
- Raymond James & Associates first reported a position in Synopsys in Q2 2015 and has held it in 37 quarters since.
- Raymond James & Associates's Synopsys position peaked at $132M in Q2 2024.
- 1,243 funds tracked by Wall St. Rank held Synopsys as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.